Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

FDA issues Warning Letter to Lovelace Biomedical over QAU failures to reconcile raw data with final GLP study reports across two nonclinical protocols.

FDA cites Hanlim Pharm for aseptic technique failures and unidirectional airflow deficiencies at its South Korea sterile fill-finish site.

FDA issues Warning Letter to SCA Pharmaceuticals over sterile compounding CGMP failures at its 503B outsourcing facility in Little Rock, Arkansas.

BMS's RYZ101 met its Phase 3 primary endpoint in GEP-NETs, raising immediate questions about radiopharmaceutical manufacturing scale-up ahead of a potential NDA.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Oct 20
Oct 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
